- Social:
Center for Disease Dynamics, Economics & Policy / Princeton University
Director of the Center for Disease Dynamics, Economics & Policy and Senior Research Scholar and Lecturer at Princeton University
PROFILE
Ramanan Laxminarayan
Guest
FROM Ramanan Laxminarayan
To the Point
Superbugs are defeating antibiotics Antibiotics have prevented and cured deadly human diseases for 80 years. But the time is coming when we might have to live without them -- if we can. The United Nations says it's finally time to take seriously the warning that overuse in human beings and farm animals is not just counter-productive. It's allowing bacteria to develop resistance, so that common conditions like tuberculosis, gonorrhea and urinary infections might well become fatal again. And pharmaceutical companies are not stepping up with new research that could lead to development of new drugs. After years of warnings, it's a global problem that demands solutions — while there's still time.
Recommended
To the Point
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.
To the Point
White House budget proposal slashes and burns President Trump's first budget request is considered dead on arrival in Congress — a familiar development in Capitol Hill. We hear what it reveals about the priorities of the new administration. What's likely to die… and what might survive?
To the Point
Replacing Obamacare: Now you see it… now you don’t As the Senate deliberates replacing Obmacare, health coverage for millions of people is at stake. There've been no public hearings, and a draft measure won't be made public. Is the House version so unpopular that that Senate is hiding a version that looks much the same?
To the Point
Will the Senate write a healthcare bill in secret? While Democrats and Republicans argue White House relations with Russia, another question is being decided behind closed doors: who gets help buying health insurance and who doesn't? We hear how the pros and cons are being shrouded in secrecy.